BioPharmChem Company of the Year Winner Announced at BPCI Impact Awards 2025

BioPharmaChem Ireland (BPCI), the Ibec group that represents the biopharmaceutical and chemical sectors, today announced the winners of the inaugural BioPharmaChem Impact Awards 2025, as part of the BioPharmaChem Impact Conference. 

Johnson & Johnson Innovative Medicine was named BioPharmaChem Company of the Year. Johnson & Johnson Innovative Medicine’s facility in Ringaskiddy is a state-of-the-art manufacturing and R&D site that produces critical medicines for patients across several therapy areas.

Commenting on the Impact 2025 winners, Dr. Sinead Keogh, Head of Sectors at Ibec and Director of BioPharmaChem Ireland said: “We are incredibly proud to recognize the exceptional work of the BioPharmaChem industry in Ireland. The achievements recognised at the inaugural Impact Awards not only highlight the strength and potential of the BioPharmaChem sector in Ireland but also set a benchmark for excellence and innovation globally. Johnson & Johnson Innovative Medicine are a perfect example of this excellence. Congratulations to them as they are named the inaugural BioPharmaChem Company of the Year. Johnson & Johnson Innovative Medicine has demonstrated just how far the industry has evolved when it comes to efficiency, productivity and contributions to biopharmachem excellence in Ireland.”

Commenting on their award, Dana Daneshvari, VP & General Manager Biotherapeutics Site, Johnson & Johnson Innovative Medicine Ringaskiddy "We are thrilled to be recognised as the BioPharmaChem Company of the Year, especially as we celebrate 20 years of our site this year. This honour reflects the incredible dedication of the many talented individuals who have walked through our doors over the past two decades. Their commitment and passion to push boundaries in biotherapeutics highlight our mission to transform patients' lives globally. This award motivates us to further continue our journey of innovation."

The awards recognise and celebrate excellence in the BioPharmaChem sector in Ireland across seven categories. 

The full list of Impact Awards 2025 winners:

• BioPharmaChem Company of the Year Award 2025: Johnson & Johnson Innovative Medicine, Ringaskiddy
• Sustainable BioPharmaChem Company of the Year Award 2025: Astellas Ireland Co. Ltd
• Collaboration in BioPharmaChem Award 2025: Boston Scientific
• Best Process Innovation/Digitalisation of the Year Award 2025: Sanofi
• Emerging BioPharmaChem Company of the Year Award 2025: Blynksolve
• BioPharmaChem Partner/Supplier of the Year Award 2025: Micro-Bio
• Best Talent Strategy of the Year Award 2025: Innopharma Technical Services
• Outstanding Contribution to BioPharmaChem 2025: Brendan O’Callaghan, EVP, Manufacturing and Supply, Sanofi

BPCI are immensely grateful to our sponsors. They include platinum sponsors; EY and SSPC. Gold sponsors; Brightbeam, Camida, Chemco, DHL Supply Chain and Innopharma and silver sponsors, BioPharmaChem Skillnet, BioPharmaChem Ireland Apprenticeships, Enterprise Ireland, IDA Ireland, Indaver, Micro-Bio, Orion GXP Consulting and WuXi Biologics.